Page last updated: 2024-08-17

edetic acid and laromustine

edetic acid has been researched along with laromustine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Penketh, PG; Rockwell, S; Sartorelli, AC; Seow, HA; Shyam, K	1

Other Studies

1 other study(ies) available for edetic acid and laromustine

Article	Year
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells. Proceedings of the National Academy of Sciences of the United States of America, 2005, Jun-28, Volume: 102, Issue:26 Topics: Animals; Antineoplastic Agents; Cell Survival; CHO Cells; Chromatography, High Pressure Liquid; Cricetinae; Cross-Linking Reagents; Cytochrome-B(5) Reductase; DNA; Dose-Response Relationship, Drug; Edetic Acid; Glutathione; Glutathione Transferase; Hydrazines; Hypoxia; Mice; Mice, Inbred BALB C; Models, Chemical; NAD(P)H Dehydrogenase (Quinone); NADPH-Ferrihemoprotein Reductase; Neoplasm Transplantation; Neoplasms; Nitrogen; Oxygen; Sulfhydryl Compounds; Sulfonamides; Time Factors; Treatment Outcome; Xanthine Oxidase; Zinc	2005

Article

Year

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.

Proceedings of the National Academy of Sciences of the United States of America, 2005, Jun-28, Volume: 102, Issue:26

Topics: Animals; Antineoplastic Agents; Cell Survival; CHO Cells; Chromatography, High Pressure Liquid; Cricetinae; Cross-Linking Reagents; Cytochrome-B(5) Reductase; DNA; Dose-Response Relationship, Drug; Edetic Acid; Glutathione; Glutathione Transferase; Hydrazines; Hypoxia; Mice; Mice, Inbred BALB C; Models, Chemical; NAD(P)H Dehydrogenase (Quinone); NADPH-Ferrihemoprotein Reductase; Neoplasm Transplantation; Neoplasms; Nitrogen; Oxygen; Sulfhydryl Compounds; Sulfonamides; Time Factors; Treatment Outcome; Xanthine Oxidase; Zinc

2005